Palisade Bio, Inc.
NASDAQ:PALI · NASDAQ Capital Market
+$0.16 today
Vol 3.86M · Avg 3.65M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+166.61%
Period High
$2.80
Period Low
$0.54
Latest
$1.87
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Leap Therapeutics, Inc.
LPTX
$31.86M
Athira Pharma, Inc.
ATHA
$26.62M
Daré Bioscience, Inc.
DARE
$20.28M
Rocket One Inc.
HOTH
$13.59M
Entero Therapeutics, Inc.
ENTO
$13.58M
Citius Pharmaceuticals, Inc.
CTXR
$6.17M
BriaCell Therapeutics Corp.
BCTX
$5.43M
Curis, Inc.
CRIS
$5.38M
Processa Pharmaceuticals, Inc.
PCSA
$4.88M
Aspire Biopharma Holdings, Inc.
ASBP
$730,305.00
What is the latest PALI filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does PALI have?
Intrinsic Alpha currently shows 20 recent filings for PALI.
Explore More
Continue the stock analysis
Jump to another research area for this company.